A link between poor quality antimalarials and malaria drug resistance?

Expert Rev Anti Infect Ther. 2016 Jun;14(6):531-3. doi: 10.1080/14787210.2016.1187560. Epub 2016 May 23.

Authors

Paul N Newton^{1

2

3}, Céline Caillet^{1

2

3}, Philippe J Guerin^{2

3}

Affiliations

¹ a Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory , Mahosot Hospital , Vientiane , Lao PDR.
² b Centre for Tropical Medicine & Global Health, NDM Research Building , University of Oxford , Oxford , UK.
³ c WorldWide Antimalarial Resistance Network (WWARN) , Centre for Tropical Medicine & Global Health, University of Oxford , Oxford , UK.

PMID: 27187060
DOI: 10.1080/14787210.2016.1187560

No abstract available

Keywords: Resistance; antimalarials; falciparum; malaria; medicine quality.

Publication types

Editorial

MeSH terms

Antimalarials / standards*
Antimalarials / therapeutic use
Artemisinins / standards
Artemisinins / therapeutic use
Chloroquine / standards
Chloroquine / therapeutic use
Drug Combinations
Drug Resistance, Microbial*
Drug Therapy, Combination
Humans
Malaria, Falciparum / drug therapy*
Plasmodium falciparum*
Pyrimethamine / standards
Pyrimethamine / therapeutic use
Sulfadoxine / standards
Sulfadoxine / therapeutic use

Substances

Antimalarials
Artemisinins
Drug Combinations
fanasil, pyrimethamine drug combination
Sulfadoxine
Chloroquine
artemisinin
Pyrimethamine